UK Exports to US Plunge 25 Following Trump Tariffs Resulting in Trade Deficit BlueCollar Workers Emerge as Winners in AI Economy ATT CEO Says Borosil Glass Works Shares Surge Over 200 in a Year Key Drivers Behind the Rally Robinhood Unveils AI Agent Tools for Trading and Spending Targeting Retail Investors Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Jim Cramer Weighs In on Atlassians YouTube Controversy What Investors Should Know BATRK Q1 2026 Earnings Loss Narrows Surpasses Analyst Expectations VOD Q4 2025 Earnings EPS Surges 408 Above Estimates Stock Edges Higher PEBK Q4 2025 Earnings EPS of 121 Surpasses Absent Estimates Shares Edge Higher REFR Q1 2026 Earnings Losses Continue with No Reported Revenue Stock Declines 066 Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Sends Stock Higher A Contradictory Market Reaction UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Units Dip Slightly TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels Nuwellis Inc NUWE Drops Over 13 as Shares Approach Critical Support Leapfrog Acquisition Corporation LFAC Holds Steady at 998 Amid Quiet Trading Diamondback Energy FANG Slips 185 as Resistance Holds Support Levels in Focus Stryker Corporation SYK Edges Higher as Price Holds Above Support Zone Waymo Temporarily Expands Robotaxi Pause in Five US Cities After Flooded Road Incidents BW Q1 2026 Earnings Wide EPS Miss Weighs on Investor Sentiment SmartKem Inc SMTK Edges Higher MicroCap Stock Holds Above Key Support After Modest Gain Enerpac Tool Group EPAC Edges Higher as Support Holds Steady NCS Multistage Holdings NCSM Eases Slightly as Traders Eye Key Support and Resistance Levels Circle Internet Group Inc CRCL Faces Resistance as Stock Pulls Back from Recent Highs ATT T Edges Lower Navigating Support and Resistance Levels Olaplex Holdings OLPX Holds Steady Near Support as Traders Eye Breakout Potential BULLW Warrants Slide 954 as Webulls Equitylinked Securities Test Key Support Nektar Therapeutics NKTR Navigates a 287 Decline as Key Support Levels Come Into Focus